Treatment
Medication clinical trials
We’re tracking 7,446 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07361224RecruitingPhase 1
Combining CLS-015 with CAR-T for large B-cell lymphoma
This trial tests combining an experimental drug (CLS-015) with a standard CAR-T cell therapy for people with large B-cell lymphoma whose disease is stable or progressing. It aims to see if the combination is safe and might improve treatment outcomes.
Tel AvivAges 18 years+ - NCT07115849Recruiting
Sex hormones and exercise response
This trial tests how different sex hormone levels affect the body's response to physical training. It may help explain why exercise works differently for different people.
Aarhus, JutlandAges 18–35 - NCT07545902Recruiting
Urea-based creams for plaque and palm-sole psoriasis
This study tests two medicated creams containing urea (a natural moisturizing ingredient) to treat psoriasis on the skin and on the palms and soles of the feet. The creams may help reduce flaking, scaling, and irritation in people with mild psoriasis.
Chieti, ItaliaAges 18–65 - NCT07049952RecruitingPhase 2/Phase 3
A feeding study for babies learning to eat
This study tests if a device (taVNS) placed on the ear can help babies born after 39 weeks who are having a hard time learning to eat by mouth. It may help them improve their feeding skills.
Charleston, South CarolinaAges 9 months–1 year - NCT07148921Recruiting
Pain perception during gender affirming hormone therapy
This study looks at how starting gender affirming hormone therapy may change your experience of pain. If you are an adult assigned female at birth planning to start testosterone, or an adult assigned male at birth planning to start estradiol, and you have not taken any sex hormones in the past six months, this trial wants to measure your pain perception over time.
Vienna, State of ViennaAges 18 years+ - NCT07170293RecruitingPhase 2
Testing tunlametinib for NRAS-mutant solid tumors
This trial tests an experimental pill (Tunlametinib) for people with solid tumors that have a specific NRAS gene change and have stopped responding to other treatments. The goal is to see if the drug can shrink or slow the growth of these tumors.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06101082RecruitingPhase 1
Testing anti-HER2-CAR-T cells for advanced solid tumors
This study tests a new type of cell therapy called anti-HER2-CAR-T for people with advanced HER2-positive solid tumors (like breast, stomach, or colon cancer) whose cancer has not responded to other treatments. The therapy uses your own immune cells engineered to target and kill cancer cells.
Shenyang, LiaoningAges 18–70 - NCT07113353Recruiting
Non-Invasive Brain Pressure Monitoring Study
This study is testing a new way to measure pressure inside the skull without needing a separate procedure. It may be an option for people having brain surgery, getting spinal taps, or needing their VP shunt adjusted.
Coppell, TexasAges 18 years+ - NCT07053657Recruiting
Vitamin D for heart health in overweight teens
This study looks at whether giving vitamin D can improve heart and metabolic health in overweight or obese teens who have low vitamin D levels. It may help lower risks like high blood sugar or cholesterol.
Anqing, AnhuiAges 10–16 - NCT06100965Recruiting
Lower dose alemtuzumab for kidney transplant rejection
This trial tests a reduced dose of alemtuzumab, a medicine that calms the immune system, for people whose kidney transplant is being rejected and standard treatments haven't worked or aren't safe.
Rotterdam, South HollandAges 18 years+ - NCT05275088Recruiting
Transcatheter valve replacement for badly calcified heart valves
This trial tests Prizvalve, a catheter-based procedure to replace a severely damaged “atrioventricular” valve in people at high risk from open-heart surgery. It may help reduce symptoms caused by valve narrowing or leaking when traditional surgery is not a good option.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07679542RecruitingPhase 1/Phase 2
Dihydroartemisinin for metabolic fatty liver disease
This trial tests whether dihydroartemisinin, a malaria drug that may reduce liver fat, helps people with metabolic fatty liver disease. It is for adults aged 18 to 45 who have a fatty liver and at least one metabolic problem like overweight, high blood pressure, or diabetes.
Nanjing, JiangsuAges 18–45 - NCT06094569Recruiting
Screening for stroke in the back of the brain
This study uses MRI scans to find strokes caused by blockages in the arteries at the back of the brain. It may help doctors learn more about these strokes and how to better care for people who have them.
Tianjin, Tianjin MunicipalityAges Any age - NCT06093282Enrolling by invitation
Community activity program for health and mood
This study tests if a community-based activity program can improve both mood and heart health in people who have limited access to healthcare or live in less-resourced neighborhoods. You may be able to join if you have symptoms of depression and are not very physically active or have a higher body weight.
Chicago, IllinoisAges 18 years+ - NCT07694778Recruiting
Functional dyspepsia in rural Bangladesh
This study looks at how common functional dyspepsia (stomach discomfort without a clear cause) is among adults living in a rural area of Bangladesh. It aims to understand who is affected and what factors might be involved.
DhakaAges 18 years+ - NCT07712445Recruiting
Testing a clot-busting drug coated with platelet membranes
This study tests a new way to deliver a clot-dissolving drug called tenecteplase. The drug is coated with platelet membranes to target blood clots in arteries. It may offer a safer, more effective treatment for heart attack patients and is also enrolling healthy volunteers for comparison.
Nanjing, JiangsuAges 18–75 - NCT07713550Recruiting
Genetic profiling to guide treatment for advanced solid tumors
This study tests whether analyzing the DNA of your tumor (from a tissue sample or blood draw) can help find the best treatment for your advanced cancer. Researchers will look for genetic changes that could make you eligible for targeted therapy or a clinical trial.
AnderlechtAges 18 years+ - NCT07705776Recruiting
SanaMente: A peer-led program for Latino/a well-being
This trial tests a peer-led program called SanaMente to help rural Latino/a adults manage stress, improve mood, and prevent or manage chronic health conditions like diabetes or heart disease. You'll join either group or one-on-one sessions focused on emotional and physical health.
Carbondale, ColoradoAges 18 years+ - NCT07625917Recruiting
Testing an online HIV prevention program for people who inject drugs
This study tests whether an internet-based HIV prevention program works for people who use injection drugs. Researchers want to see if online tools can help reduce HIV risk and improve health outcomes.
The Bronx, New YorkAges 18 years+ - NCT07621120Recruiting
Wearable Device to Predict Surgery Risk in Older Adults
This study uses a wristwatch-like device to measure your movement and body functions before and after surgery to help predict which older patients might have complications. The goal is to improve safety planning for people 65 and older having surgery.
Beijing, Beijing MunicipalityAges 65 years+ - NCT07620002Recruiting
Monitoring Pain Levels During Arm Surgery With Nerve Block
This study tests a device that measures pain levels during upper arm surgery when patients receive a nerve block (numbing medicine injected near the nerve). The goal is to understand if this monitoring tool helps doctors give the right amount of anesthesia so patients stay comfortable.
HaifaAges 18 years+ - NCT07618936Recruiting
PD-L1 PET/CT imaging scan for cancer patients
This trial tests a new type of imaging scan (PD-L1 PET/CT) that may help doctors better see and understand cancers. The scan uses a special tracer to highlight cancer cells in your body, which could help guide treatment decisions.
Hefei, AnhuiAges 18–80 - NCT07630155Recruiting
Single-use digital scope for kidney cancer surveillance
This trial tests a new, disposable flexible camera (ureteroscope) to safely check for or monitor upper urinary tract cancer in an office setting without putting you to sleep. The goal is to see if patients can tolerate this procedure comfortably while awake.
Ann Arbor, MichiganAges 18 years+ - NCT07675863Recruiting
Communication delays and anesthesia in emergencies
This study tests how communication delays affect anesthesia responses during medical emergencies and ultrasound-guided procedures. It may help identify ways to improve teamwork and safety in critical situations.
Halifax, Nova ScotiaAges Any age
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,446 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.